Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasGeneral adult psychiatry — somatic symptom and related

Psych Vivas · General adult psychiatry — somatic symptom and related

Illness anxiety disorder — structured clinical viva

Fellowship viva on IAD in CL cardiology: nosology, CBT, CHAMP, SSRI, collaborative care, risk.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar on the CL service. A 45-year-old man on the cardiology ward has had three normal angiograms over 2 years for recurrent chest tightness. Troponins and ECGs are repeatedly normal. He is convinced he has 'missed coronary disease' (poor insight), checks his pulse every 15 minutes, and demands another angiogram tonight. He meets criteria for illness anxiety disorder with care-seeking behaviour and comorbid depression. Nursing staff call him a 'heartsink' patient. Discuss diagnosis vs SSD and delusional disorder, the CBT model, CHAMP relevance, SSRI options with doses, collaborative care, and suicide/mortality risk framing.

Interpretation

Reveal interpretation

This is illness anxiety disorder (care-seeking) in a medical setting, not automatically SSD (somatic load is intermittent chest tightness with disease fear dominating after negative work-up) and not automatically delusional disorder if anxiety-driven checking and seeking dominate without a broader psychotic process. Poor insight is compatible with severe IAD; treat the health-anxiety pathway.[5][4]

Cardiology clinics have high rates of significant health anxiety — this presentation is common, not rare nuisance behaviour. Avoid pejorative “heartsink” framing; it predicts staff countertransference and missed treatable anxiety.[7]

Psychological plan. Warwick–Salkovskis cycle: catastrophic cardiac misinterpretation → pulse checking and angiogram seeking → brief relief → maintained belief. Offer specialised CBT for health anxiety (exposure, response prevention for checking/reassurance, behavioural experiments). CHAMP supports adapted CBT-HA for medical outpatients as clinically effective and cost-effective.[1][4]

Pharmacotherapy. Optimise SSRI for health anxiety and depression: options with trial anchors include paroxetine (Greeven RCT) or fluoxetine (Fallon RCTs), e.g. fluoxetine often starting 20 mg orally daily with titration and monitoring; sertraline is a pragmatic alternative. Combine with CBT when feasible; joint treatment showed incremental benefit in Fallon’s multi-arm design framework.[2][3]

Collaborative care. Named cardiology/GP medical home; written criteria for re-investigation if new objective red flags; scheduled reviews rather than on-demand angiograms; both–and formulation. Decline non-indicated invasive testing that maintains threat.[1]

Risk. Assess suicide thoroughly — hypochondriasis cohorts show elevated mortality including suicide. Treat depression actively.[6]

Key points

CL is core, not optional

Health anxiety is common in specialty clinics; CHAMP-style CBT-HA is examinable.

IAD ≠ delusion by default

Poor insight still usually treated with CBT/SSRI health-anxiety pathways.

Mortality is real

Do not trivialise; assess suicide and comorbidity.[1][6]

References

  1. [1]Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial Lancet, 2014.PMID 24139977
  2. [2]Greeven A, van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial Am J Psychiatry, 2007.PMID 17202549
  3. [3]Fallon BA, Ahern DK, Pavlicova M, et al. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis Am J Psychiatry, 2017.PMID 28659038
  4. [4]Warwick HM, Salkovskis PM Hypochondriasis Behav Res Ther, 1990.PMID 2183757
  5. [5]Dimsdale JE, Creed F, Escobar J, et al. Somatic symptom disorder: an important change in DSM J Psychosom Res, 2013.PMID 23972410
  6. [6]Mataix-Cols D, Isomura K, Sidorchuk A, et al. All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis JAMA Psychiatry, 2024.PMID 38091000
  7. [7]Tyrer P, Cooper S, Crawford M, et al. Prevalence of health anxiety problems in medical clinics J Psychosom Res, 2011.PMID 22118381